Products
Investing
Resources
Support
NATCO Pharma Limited (NATCOPHARM)
₹850.9
INR+6.40(+0.76%)
As of April 30, 2025 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹16082.40 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹13669.83 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
8.49
Forward P/E
Price to Earnings ratio based on forecasted earnings
21.41
PEG Ratio
Price/Earnings to Growth ratio
21.41
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
3.76
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
82.56%
Operating Margin
Operating income as a percentage of revenue
-1.73%
Return on Equity
Net income as a percentage of shareholders' equity
23.72%
Revenue (TTM)
Total revenue over trailing 12 months
₹4280.00 Cr-37.4%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹2468.20 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹104.13-37.5%
Balance Sheet
Total Cash
Total cash and short-term investments
₹2463.40 Cr
Total Debt
Total short-term and long-term debt
₹208.40 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
2.91%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹726.8 - ₹1639
Beta
Measure of stock's volatility compared to the market
0.44
Shares Outstanding
Total number of shares issued by the company
₹17.91 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.68%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.82%
Payout Ratio
Percentage of earnings paid as dividends
5.52%